CAS 261953-36-0

6-iodo-1H-indazole

Codes：AXIT-022

Application context (from source-drug indications)

肾细胞癌阿昔替尼神经内分泌瘤阿昔替尼腺样囊性癌阿昔替尼副神经节瘤阿昔替尼嗜铬细胞瘤阿昔替尼导管癌阿昔替尼

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
阿昔替尼Axitinib	Tier B — Position early	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

阿昔替尼工艺路线steps: 3total yield: 28 kg

2-vinylpyridine→2-mercapto-N-methylbenzamide→6-iodo-1H-indazole→2-((1H-indazol-6-yl)thio)-N-methylbenzamide→2-((3-iodo-1H-indazol-6-yl)thio)-N-methylbenzamide

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

Supplier	Product	Price band	MOQ	Lead time	Qualifications
Unibest Nantong cGMP Site	6-Iodo-1H-indazole Pharmaceutical Intermediates	询价	询价	询价	—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.